Blue Premier ties payments to doctors and hospitals over time to the value of services that improve patient health
Closing Gaps in Health Plan Performance with Stakeholder Collaboration Published in American Health & Drug Benefits, October 2015, Vol 8, No 7, Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment F. Randy Vogenberg, PhD, RPh, Partner, Access Market Intelligence Employers/Health Plans: For most commercial health plans and employer-sponsored health plans, immunology represents a […]
Specialty Drug Wave Hitting Medical and Pharmacy Plans Harder: Trends versus reliable benefit strategy to handle the impact through 2020?The U.S. now has two different markets resulting from implementation of the Affordable Care Act (ACA) and resultant trends. Related to specialty or biological drugs, public sector CMS’s forecast of drug spending is somewhat counterintuitive, given […]